Ohio State University Comprehensive Cancer Center
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.cancer.osu.edu
B3 Buddy for Securing Urinary Drainage Bag to Patient While Walking
- Conditions
- Urinary System Disorder
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 41
- Registration Number
- NCT06571058
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
- Conditions
- BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
- First Posted Date
- 2024-08-02
- Last Posted Date
- 2025-06-27
- Target Recruit Count
- 152
- Registration Number
- NCT06534424
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
πΊπΈHuntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
- Conditions
- Soft Tissue Sarcoma
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-10-31
- Target Recruit Count
- 30
- Registration Number
- NCT06500065
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Manipulating E-Cigarette Nicotine to Promote Public Health
- Conditions
- Tobacco-Related Carcinoma
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2025-06-04
- Target Recruit Count
- 350
- Registration Number
- NCT06448351
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial
- Conditions
- Lung Carcinoma
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2025-06-03
- Target Recruit Count
- 88
- Registration Number
- NCT06445192
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
- Conditions
- Low Anterior Resection SyndromeRectal Carcinoma
- Interventions
- Dietary Supplement: Dietary FiberProcedure: Enema AdministrationProcedure: Physical TherapyOther: Questionnaire AdministrationProcedure: X-Ray Imaging
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2025-06-25
- Target Recruit Count
- 80
- Registration Number
- NCT06424522
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- Conditions
- Malignant Thoracic Neoplasm
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2025-05-31
- Target Recruit Count
- 157
- Registration Number
- NCT06396598
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer
- Conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-06-29
- Target Recruit Count
- 60
- Registration Number
- NCT06391099
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
- Conditions
- Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8
- Interventions
- Procedure: Biospecimen CollectionOther: Contrast AgentProcedure: Magnetic Resonance ImagingOther: Physical Performance Testing
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-03-26
- Target Recruit Count
- 70
- Registration Number
- NCT06330805
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
- Conditions
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC V8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC V8Oropharyngeal Squamous Cell Carcinoma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyRadiation: External Beam Radiation TherapyProcedure: Positron Emission TomographyOther: Questionnaire Administration
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2025-02-14
- Target Recruit Count
- 45
- Registration Number
- NCT06323460
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States